Chief Physician, Master's Supervisor, Master's Degree, Doctor of Medicine Candidate Specializes in the diagnosis and treatment of benign and malignant tumors of the biliary and pancreatic systems and biliary tract stones, as well as various minimally invasive and traditional surgeries. In 2001, entered Shanghai Jiao Tong University School of Medicine; in 2008, completed postgraduate studies and began working on the clinical front line; in 2013, appointed as Attending Physician; in 2018, appointed as Associate Chief Physician; in 2019, rated as Master's Supervisor; in 2023, appointed as Chief Physician. Has long been engaged in clinical front-line work in general surgery, focusing on the diagnosis and treatment of biliary and pancreatic diseases and abdominal wall hernias, skillfully performing various hepatobiliary and pancreatic surgeries, and possessing rich experience in handling difficult clinical cases. In clinical work, has cumulatively completed nearly 1,000 surgeries for various benign and malignant biliary and pancreatic tumors, and nearly 10,000 laparoscopic biliary and laparoscopic gallbladder surgeries, possessing rich clinical diagnostic and surgical capabilities. In terms of scientific research, has undertaken multiple projects including those from the National Natural Science Foundation of China, the Shanghai Key Laboratory of Nucleic Acid Chemistry and Nanomedicine, the Municipal Education Commission, and Shanghai Jiao Tong University School of Medicine, with cumulative impact factors of published SCI papers exceeding 60 points, and has published clinical papers in major domestic core journals. In terms of teaching, as a Master's Supervisor and PBL and CBL lecturer, has been diligently striving to cultivate new medical talents.